Authors
Latest:
Pharmacotherapy Options for COVID-19: Does Fluvoxamine Have a Place in Therapy?The need for safe and effective treatment against the various strains of COVID-19 increase, and investigators continue to assess various pharmacologic options.
Latest:
Infectious Diseases Provider Role in Extracorporeal Membrane Oxygenation InfectionsThere has been an emergence of extracorporeal membrane oxygenation-associated infections. Here is a review of how to define them and clinical management of this heterogeneous syndrome.
Latest:
Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D VirusesThe healthcare sector currently faces an unmet need in treating herpesviruses, hepatitis B, and hepatitis D, which could significantly improve patient outcomes. Addressing this involves considering the necessary steps and understanding the challenges pharmaceutical companies encounter as they work towards developing treatments for these conditions.
Latest:
Updates and Controversies in Necrotizing Soft Tissue InfectionsChanges in microbiology and antimicrobial resistance patterns warrant reevaluation of our current therapies for this condition.
Latest:
Gram-Negative Antibiotic Discovery Innovator Initiative to Drive Global Collaboration in Addressing AMR ChallengesKen Duncan, PhD, discussed the launch of a $50 million initiative focused on developing new drugs for critical pathogens contributing to antimicrobial resistance.
Latest:
CDC Influenza Surveillance Weekly ReportClinical and public health laboratories reported increased influenza virus detections over the past few weeks, but US cases remains comparatively low to previous flu seasons.
Latest:
Infection Control: AP Technology's Impact on Reducing HAIs and AMR PathogensDeborah Birx, MD, and Amy Carenza, BBA, highlight the targeting of multidrug-resistant organisms and tracking of infection trends without increasing staffing needs.
Latest:
The Importance of Local Health Departments in Combating HAIs and AMRNACCHO’s CEO Lori Tremmel Freeman discusses efforts and emphasizes the need for federal support and coordination.
Latest:
Linezolid Coadministration With Medications for Opioid Use Disorder: A Serotonin Toxicity Tightrope?This study characterized the incidence of serotonin syndrome and identified contributing risk factors with combined medications for opioid use disorder (MOUD) and linezolid use.
Latest:
Sorry Ganciclovir, You’re Just Not the One for MeImportant clinical considerations to know about resistant CMV infections.
Latest:
The Role of Pharmacists in the World of Pediatric Antimicrobial StewardshipThe limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.
Latest:
The ART of Implementing an Antiretroviral Stewardship ProgramBy addressing ART-related medication errors and increasing linkage to care, antiretroviral stewardship programs can improve management of inpatients with HIV.
Latest:
Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant RecipientExpanding the differential for diarrhea beyond Clostridium difficile.
Latest:
Using Deep Sequencing Technology to Detect HCV Resistant VariantsA research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.
Latest:
The ID Pipeline: Drug Development Debrief | Week of September 13, 2020A quick debrief of the week’s top FDA approvals, FDA authorizations, or other infectious disease pipeline developments from the past week.
Latest:
Medical Importance of Microbial Biofilms in the Management of Infectious DiseasesBiofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.
Latest:
MSM Who Use Mobile Apps for Sex More Likely to Have STIsMen who have sex with men who seek out sexual partners online are more likely to report sexually transmitted infections, including syphilis, gonorrhea, and chlamydia.
Latest:
The Significance of Antimicrobial Stewardship in DentistryDebra Goff, PharmD, discusses her advocacy around this topic and bringing the stewardship message to dentists about how antibiotic prescribing practices have changed and getting them to recalibrate their thinking and actions in their field.
Latest:
Treatment as Prevention: A Comprehensive Approach to Hepatitis C Virus in Persons Who Inject DrugsWith IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.
Latest:
Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUCThis In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.
Latest:
Tick, Tick, Tick: Vector-Borne Diseases Ramp UpInfections transmitted by these bloodsucking species are on the rise worldwide.
Latest:
Will Pennsylvania Proposal Sanction Improper Treatment of Lyme Disease?Amesh A. Adalja, MD, FIDSA argues that a bill being considered in the Pennsylvania state legislature will ultimately result in increased antibiotic resistance and will set back the clock for finding appropriate treatments for Lyme disease.
Latest:
Manual Surface Disinfectants Must Continue to Evolve to Meet Changing Health Care NeedsMany health care facilities are looking to expand the use of broad-spectrum sporicidal disinfectants beyond patient isolation rooms to better address the role of the environment in pathogen transmission and acquisition.
Latest:
CIDRAP Launches its Vaccine Integrity ProjectThe University of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP) announced its initiative that will look to ensure reliable vaccine data and information is available to the public and medical community.
Latest:
CREating New Strategies for the Treatment of Resistant Gram-Negative InfectionsThis was the first study to compare clinical outcomes in carbapenemase-producing (CP-CRE) and non–carbapenemase-producing (nCP-CRE) infections.
